Corpus Intelligence IC Memo — HENDRICKS REGIONAL HEALTH 2026-04-26 05:29 UTC
IC Memo — HENDRICKS REGIONAL HEALTH
Investment Committee Memorandum | IN | 130 beds | Grade B | EBITDA uplift $31.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HENDRICKS REGIONAL HEALTH

CCN 150005 | HENDRICKS, IN | 130 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

HENDRICKS REGIONAL HEALTH is a 130-bed suburban community hospital in HENDRICKS, IN with $423.4M in net patient revenue and a -3.6% operating margin. The hospital serves a payer mix of 28.6% Medicare, 2.7% Medicaid, and 68.7% commercial.

Thesis: Undervalued. Our ML models identify $31.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.6% to 3.8% (+736bps).

Net Revenue HCRIS$423.4M
Current EBITDA COMPUTED$-15.2M
Operating Margin COMPUTED-3.6%
Occupancy HCRIS49.4%
Revenue / Bed COMPUTED$3.3M
Net-to-Gross HCRIS35.3%
Distress Probability ML45.6%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
53
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of -3.6% places it below the state median. Among 53 size-comparable peers (65-260 beds), the median margin is 6.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (65-260), prioritizing same-state peers. 53 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HENDRICKS REGIONAL HEALTH (Target)IN130$423.4M-3.6%
UNION HOSPITAL INC.IN258$581.9M3.8%
IU HEALTH BLOOMINGTON HOSPITALIN210$529.4M6.2%
REID HOSPITAL & HEALTH CARE SEIN183$487.2M26.1%
IU HEALTH ARNETT HOSPITALIN194$426.2M16.1%
IU HEALTH NORTH HOSPITALIN153$413.3M24.2%
FRANCISCAN HEALTH LAFAYETTEIN177$377.7M2.7%
PORTER REGIONAL HOSPITALIN199$370.6M22.1%
COLUMBUS REGIONAL HOSPITALIN223$361.8M-0.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $31.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$8.9M+210bp18mo
Cost to Collect4.5%2.5%$8.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$8.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$5.2M+122bp9mo
Clean Claim Rate88.0%96.0%$271K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$8.9M
Cost to Collect
$8.5M
Denial Rate Reduction
$8.4M
A/R Days Reduction
$5.2M
Clean Claim Rate
$271K
Total EBITDA Uplift$31.2M
Current EBITDA$-15.2M
+ RCM Uplift+$31.2M
Pro Forma EBITDA$16.0M
Current Margin-3.6%
Pro Forma Margin3.8%
WC Released (1x)$16.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-23.4M$211.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-23.4M$224.8M0.00x-100.0%
Bull Case9.0x11.0x$-21.1M$320.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-21.1M$343.0M0.00x-100.0%
Bear Case11.0x10.0x$-25.7M$63.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-25.7M$61.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 53 hospitals with 65-260 beds
  • Same-state prioritization (n=54)
  • Comp margins: P25=-8.6% / P50=6.2% / P75=18.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.